Mraz Amerine & Associates’s Merck MRK Stock Holding History

Mraz Amerine & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Sell	15,118 -91	-0.6%	-$10.7K	0.28%	61
2026 Q1	$1.83M	Buy	15,209 +1	+0%	+$115	0.27%	65
2025 Q4	$1.6M	Buy	15,208 +402	+3%	+$37.7K	0.24%	67
2025 Q3	$1.24M	Buy	14,806 +11,078	+297%	+$912K	0.19%	81
2025 Q2	$295K	Buy	3,728 +1,000	+37%	+$79.5K	0.05%	149
2025 Q1	$243K	Buy	+2,728	New	+$255K	0.04%	146
2024 Q4	–	Sell	-2,066	Closed	-$235K	–	171
2024 Q3	$235K	Sell	2,066 -10	-0.5%	-$1.19K	0.04%	144
2024 Q2	$257K	Hold	2,076	–	–	0.05%	138
2024 Q1	$274K	Hold	2,076	–	–	0.05%	143
2023 Q4	$226K	Hold	2,076	–	–	0.05%	156
2023 Q3	$214K	Hold	2,076	–	–	0.05%	157
2023 Q2	$240K	Sell	2,076 -590	-22%	-$67K	0.06%	151
2023 Q1	$284K	Hold	2,666	–	–	0.07%	138
2022 Q4	$296K	Hold	2,666	–	–	0.07%	136
2022 Q3	$230K	Hold	2,666	–	–	0.06%	138
2022 Q2	$243K	Hold	2,666	–	–	0.06%	140
2022 Q1	$219K	Hold	2,666	–	–	0.05%	150
2021 Q4	$204K	Hold	2,666	–	–	0.05%	156
2021 Q3	$200K	Hold	2,666	–	–	0.05%	159
2021 Q2	$207K	Sell	2,666 -65	-2%	-$4.83K	0.06%	161
2021 Q1	$201K	Hold	2,731	–	–	0.06%	152
2020 Q4	$213K	Hold	2,731	–	–	0.07%	136
2020 Q3	$216K	Hold	2,731	–	–	0.08%	130
2020 Q2	$202K	Hold	2,731	–	–	0.08%	128
2020 Q1	$201K	Sell	2,731 -604	-18%	-$47.5K	0.08%	120
2019 Q4	$289K	Hold	3,335	–	–	0.08%	125
2019 Q3	$268K	Sell	3,335 -629	-16%	-$50.4K	0.08%	126
2019 Q2	$317K	Sell	3,964 -104	-3%	-$7.96K	0.09%	120
2019 Q1	$323K	Sell	4,068 -495	-11%	-$37K	0.1%	119
2018 Q4	$333K	Hold	4,563	–	–	0.11%	117
2018 Q3	$309K	Buy	4,563 +56	+1%	+$3.57K	0.09%	126
2018 Q2	$261K	Sell	4,507 -10	-0.2%	-$564	0.08%	135
2018 Q1	$235K	Buy	4,517 +24	+0.5%	+$1.3K	0.07%	130
2017 Q4	$241K	Sell	4,493 -133	-3%	-$7.37K	0.07%	129
2017 Q3	$283K	Sell	4,626 -477	-9%	-$28.9K	0.09%	120
2017 Q2	$312K	Hold	5,103	–	–	0.1%	119
2017 Q1	$303K	Sell	5,103 -760	-13%	-$46.1K	0.09%	120
2016 Q4	$329K	Buy	5,863 +6	+0.1%	+$351	0.1%	115
2016 Q3	$349K	Buy	5,857 +5	+0.1%	+$292	0.12%	109
2016 Q2	$322K	Buy	5,852 +6	+0.1%	+$319	0.11%	105
2016 Q1	$295K	Sell	5,846 -36	-0.6%	-$1.76K	0.11%	111
2015 Q4	$296K	Buy	5,882 +142	+2%	+$7.16K	0.11%	108
2015 Q3	$271K	Sell	5,740 -298	-5%	-$15.8K	0.11%	109
2015 Q2	$328K	Buy	6,038 +6	+0.1%	+$337	0.12%	106
2015 Q1	$331K	Buy	6,032 +5	+0.1%	+$283	0.12%	101
2014 Q4	$327K	Buy	6,027 +709	+13%	+$39.5K	0.12%	103
2014 Q3	$301K	Buy	5,318 +193	+4%	+$10.8K	0.12%	109
2014 Q2	$283K	Sell	5,125 -98	-2%	-$5.35K	0.11%	108
2014 Q1	$283K	Buy	5,223 +85	+2%	+$4.4K	0.12%	105
2013 Q4	$245K	Buy	5,138 +6	+0.1%	+$274	0.11%	114
2013 Q3	$233K	Sell	5,132 -843	-14%	-$38.5K	0.11%	109
2013 Q2	$265K	Buy	+5,975	New	+$267K	0.13%	97

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mraz Amerine & Associates's MRK Position: Q2 2026 in Review

Mraz Amerine & Associates reduced its Merck (MRK) stake by 0.6% in Q2 2026, selling an estimated $10.7K and leaving 15,118 shares worth $1.94M. The position accounts for 0.28% of the portfolio, ranked #61.

Mraz Amerine & Associates first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Mraz Amerine & Associates held 15,118 shares of Merck worth $1.94M as of Q2 2026.
Mraz Amerine & Associates sold 91 Merck shares in Q2 2026, an estimated $10.7K.
Merck made up 0.28% of Mraz Amerine & Associates's portfolio in Q2 2026, its #61 holding.
Mraz Amerine & Associates first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.